The Bern Rehab Registry

Condition(s) studied

Investigational drug(s) / intervention(s)

Comprehensive disease-specific rehabilitation: Participation in (a) inpatient rehabilitation, (b) outpatient centre-based, (c) outpatient digitally-enhanced centre- and home-based, or (d) outpatient home-based digital/tele rehabilitation. Duration is 3 weeks for inpatient and 12 weeks for outpatient programmes.

Study summary

This study examines the health outcomes of patients with long-term illnesses such as cancer, heart, lung, or musculoskeletal diseases who participate in a rehabilitation programme. The programme may involve staying in a facility (inpatient), visiting a facility (outpatient), home-based care supported by digital health tools (telerehabilitation), or a combination of facility- and home-based options.

The key health outcomes being measured include physical fitness and strength, body composition (like body fat and muscle mass), specific risk factors related to the diseases, and patients' self-reported health and experience outcomes, such as feelings of anxiety, depression, fatigue, overall quality of life, and satisfaction with the rehabilitation programme.

These measurements provide important information about the patients' lung, heart, and muscle health, as well as their mental well-being. They also help to predict the likelihood of further health complications, the chance of needing to be hospitalized again, and overall quality of life. This information is useful for improving the quality of care, tailoring future provision of rehabilitation services and long-term care for patients with chronic conditions.

Additionally, the study will provide insights into how new technologies like telerehabilitation are implemented, including how well they are adopted, followed, and accepted by patients.

Eligibility

Primary outcome measure(s)

• Short-term change (absolute and percentage) in cardiorespiratory fitness, measured as peak oxygen uptake (ml/min/kg) or 6 minute walking test (m) — From rehabilitation entry to discharge (3 weeks for inpatient, 12 weeks for outpatient programmes)
  Stratified by type of delivery and cohort
• Long-term change (absolute and percentage) in cardiorespiratory fitness, measured as peak oxygen uptake (ml/min/kg) or 6 minute walking test (m) — From discharge (3 weeks for inpatient, 12 weeks for outpatient programmes) to one year follow-up
  Stratified by type of delivery and cohort

Trial sites (2)

More Insel Gruppe AG, University Hospital Bern trials in Switzerland

Other trials for the same condition